Filing Flows › iSpecimen (ISPC) › Q1 2026 › vs Q1 2025
iSpecimen (ISPC) Q1 2026 vs Q1 2025 (year over year)
iSpecimen's revenue fell $902K (-85%) from $1.1M in Q1 2025 to $156K in Q1 2026. The biggest changes: Product −$843K (-86%); Shipping and Handling −$59K (-73%).
iSpecimen, Q1 2026: revenue $156K (-85% year over year), net loss $2.3M, operating cash flow −$3.4M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Product | $134K | $977K | −$843K | -86% |
| Shipping and Handling | $22K | $81K | −$59K | -73% |
| Revenue | $156K | $1.1M | −$902K | -85% |
| Other income, net | $263K | −$20K | $283K | — |
| Net loss | $2.3M | $1.7M | $617K | +37% |
| Costs & expenses | $2.7M | $2.7M | −$21K | -0.8% |
| Operating costs | $2.7M | $2.7M | −$1K | -0.1% |
| Cost of revenue | $84K | $609K | −$525K | -86% |
| Sales & marketing | $1.5M | $347K | $1.2M | +344% |
| General & admin | $680K | $759K | −$78K | -10% |
| Other operating costs | $387K | $981K | −$593K | -61% |
| Operating cash sources | $3.5M | $1.5M | $2.0M | +127% |
| Depreciation & amortization | $136K | $433K | −$297K | -69% |
| Share-based compensation | $1K | $16K | −$15K | -94% |
| Cash used in operations | $3.4M | $1.1M | $2.3M | +207% |
| Net loss absorbed | $2.3M | $1.7M | $617K | +37% |
| Working capital & other | $1.2M | −$114K | $1.3M | — |
Questions
How much did iSpecimen's revenue grow year over year in Q1 2026?
iSpecimen's revenue fell $902K (-85%) from $1.1M in Q1 2025 to $156K in Q1 2026.
What drove iSpecimen's revenue change in Q1 2026?
Product −$843K (-86%); Shipping and Handling −$59K (-73%).